俞加正 祁鋒 李響芝

【摘要】目的:探討妊娠期合并梅毒的臨床治療方法及效果。方法:選取我院2012年6月至2015年6月間收治的120例妊娠合并梅毒的孕婦作為研究對象,將其依據全程是否抗梅毒治療進行分為治療組(70例)與未治療組(50例),觀察兩組母嬰結局和新生兒先天梅毒狀況。結果:治療組足月兒、存活兒、流產與死胎兒以及存活兒比例分別為90.2%、2.9%、7.1%、92.9%,未治療組中足月兒、存活兒、流產與死胎兒以及存活兒比例分別為30.0%、18.0%、52.0%、48.0%,兩組的臨床數據比較差異有統計學意義(P<0.05)。治療組中先天梅毒發生率18.5%,明顯的低于未治療組的83.3%,兩組的數據比較差異有統計學意義(P<0.05)。結論:臨床中對于妊娠期合并梅毒孕婦早期實施規范抗梅毒治療是可行的,能夠改善母嬰結局,控制新生兒先天梅毒的情況。
【關鍵詞】妊娠;梅毒;臨床治療;母嬰結局
【Abstract】Objectives: To investigate the clinical treatment of pregnant women with syphilis and its effect. Methods: 120 pregnant women with syphilis in hospital between June 2012 and June 2015 were selected and divided into treatment group (70 cases) and non-treatment group (50 cases) according to whether received whole anti-syphilis treatment or not. The maternal and neonatal outcomes and congenital syphilis status of the two groups was compared. Results: The full-term children, child survival rate, abortion and fetal death were 90.2%, 2.9%, 7.1% and 92.9% respectively in treatment group, while those in the non-treatment group were 30.0%, 18.0%, 52.0% and 48.0% accordingly, with statistically significant difference (P<0.05). The incidence of congenital syphilis in treatment group was 18.5%, significantly lower than the 83.3% of non-treatment group, with statistically significant difference (P<0.05). Conclusion: Early implementation of standardized anti-syphilis therapy is feasible in treating pregnant women with syphilis, which can improve maternal and child outcomes and reduce incidence of neonatal congenital syphilis.
【Key words】Pregnancy; Syphilis; Clinical treatment; Maternal and neonatal outcomes
【中圖分類號】R759.1【文獻標志碼】A
妊娠期合并梅毒在妊娠期中比較常見,主要是妊娠期發生或者出現活動梅毒。一般的情況下,梅毒螺旋體能夠感染胎盤與胎兒,很容易引起流產和死胎的情況,嚴重的威脅到母嬰的生命[1]。因此,本次研究重點對我院收治的120例妊娠期梅毒孕婦臨床治療情況進行分析,旨在提高該病的治療效果,改善母嬰結局,具體的分析如下。
1資料與方法
1.1研究資料
選取醫院2012年6月至2015年6月入院之后進行靜脈血的快速血漿反應試驗檢查與梅毒螺旋體被動顆粒凝聚試驗陽性的120例妊娠患者作為研究對象,且均知情同意,經過醫院倫理委員會同意。
納入標準:(1)孕婦或者其配偶伴有婚外性行為,且有梅毒感染史,孕婦具備梅毒各個時期的臨床癥狀與體征;(2)經過醫院倫理委員會批準同意的孕婦;(3)孕婦知情同意,愿意參加此次研究。
排除標準:(1)不符合臨床中妊娠期梅毒的診斷標準;……